Case report: A successful clinical experience of transplantation of liver and kidney from a donor with myelodysplastic syndromes

Front Immunol. 2024 Apr 3:15:1360955. doi: 10.3389/fimmu.2024.1360955. eCollection 2024.

Abstract

With a shortage of organs for transplant, the use of marginal donors can be an effective measure to meet the shortfall. Myelodysplastic syndromes (MDS) are considered an absolute contraindication for organ donation because of the high invasive potential. Currently, organ transplantation from donors with a past history of MDS has not been reported. In this paper, we report the successful clinical experience of one liver transplantation and two kidney transplantations, with organs donated by a 39-year-old patient diagnosed with a past history of MDS following intracranial hemorrhage. Four and a half years after transplantation, the three recipients are all doing well. However, it is still not clear to what extent organs donated by patients with a past history of MDS can be safely transplanted. This report provides support for the careful use of marginal donors. With effective treatment and full peer assessment, livers and kidneys from donors with a past history of MDS may be safely transplanted.

Keywords: malignancy transmission; marginal donors; myelodysplastic syndromes; organ donation; organ transplantation.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Humans
  • Kidney
  • Liver
  • Liver Transplantation*
  • Myelodysplastic Syndromes*
  • Tissue Donors

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. Natural Science Foundation of Hubei Province of China, Grant No. 2022CF679 Hubei Province health and family planning scientific research project, Grant No. WJ2023F014 Medical Science Advancement Program (Clinical Medicine) of Wuhan University, Grant No. TFLC2018003 National Natural Science Foundation of China, Grant No. 81970548